People

Jonathan Hirsch

synapticure.com

Chief Strategy and Growth Officer at Paradigm Health, working on wider access to clinical research. He previously co-founded Synapticure and chaired its advisory board. His Stanford biological sciences training specialized in neuroscience. Jonathan Hirsch — Synapticure publishes the following professional biography and affiliation: Jonathan Hirsch is a company founder, investor, and advisor at the intersection of healthcare, life sciences, and data. Jonathan founded Syapse in 2008, and during more than a decade of building the company, Jonathan defined and implemented a vision for transforming cancer care through precision medicine and real world evidence. Jonathan serves on the Advisory Boards of companies including Freenome, VizAI, and PaigeAI, and has helped shape the regulatory use of real world evidence through creating and serving as Principal Investigator for a Research Collaboration with the FDA. Jonathan has catalyzed national cancer data sharing networks, including serving on the White House Cancer Moonshot Data Sharing Working Group. As both an active investor and partner in venture funds, including the Kleiner Perkins seed fund and Rebel Fund, Jonathan has incubated and invested in dozens of companies at the intersection of healthcare and technology. The affiliation is scientific/strategic advice; outside employer and university titles remain external.